View of A follow up study of warning letters issued by US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a situational analysis during COVID-19 pandemic

Return to Article Details A follow up study of warning letters issued by US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a situational analysis during COVID-19 pandemic Download Download PDF